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Sub-internal limiting membrane (sub-ILM) hemorrhage is a relatively rare disease which is associated
with different etiologies and often leads to loss of visual acuity. We report two cases of sub-ILM hem-
orrhage, both conﬁrmed by optical coherence tomography (OCT) and treated with an intravitreal in-
jection of tissue plasminogen activator (tPA) followed by an octaﬂuoropropane (C3F8) pneumopexy and a
strict postoperative prone positioning. The hemorrhage was totally resolved and complete visual re-
covery was achieved in both cases. We found tPA hemolysis with C3F8 pneumopexy to be a safe and
effective method for treating sub-ILM hemorrhage.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Sub-internal limiting membrane (sub-ILM) hemorrhage is an
uncommon disease which often leads to severe visual loss. Various
causes are reported including Valsalva retinopathy, blood dyscrasia,
Terson syndrome, and ocular trauma.1 Patients with sub-ILM
hemorrhage can be observed only without intervention, but the
hemorrhage may take months to clear and induces further dam-
age.2 Several treatments have been reported, such as vitrectomy
and puncturing the ILM by green argon laser and neodymium-
doped yttrium aluminum garnet (Nd:YAG) laser.1e3 Outcomes
vary with different speciﬁc approaches. In subretinal hemorrhage,
intravitreal injection of tissue plasminogen activator (tPA) followed
by pneumopexy has been reported to be effective in clearing the
hemorrahge.4 We applied this management to treat two cases of
sub-ILM hemorrhage due to different causes and assessed the
efﬁcacy.e are no conﬂicts of interest
n this article.
logy, Taipei Veterans General
District, Taipei 11217, Taiwan.
ciety of Taiwan. Published by Else2. Case Reports
This study examined two eyes of two patients with sub-ILM
hemorrhage due to different causes. Preoperative examinations
included best-corrected visual acuity (BCVA), intraocular pressure
(IOP), fundus photograph, ﬂuorescein angiography (FA), and optical
coherence tomography (OCT). After giving informed consent, both
patients received a tPA injection followed by an octaﬂuoropropane
(C3F8) gas injection.
Under local anesthesia, 50 mg of tPA in 0.1 mL balanced salt
solution was injected intravitreally through the pars plana. The
patient was kept supine for 4 hours. Then, following an anterior
chamber paracentesis, 0.4 mL pure C3F8 was injected into the vit-
reous cavity through the pars plana. The patient then changed to a
prone position. No complications were noted during the pro-
cedures and multiple follow-up examinations were scheduled in
both cases.
2.1. Case 1
A 44-year-old woman was referred to our clinic for sudden vi-
sual loss of the right eye after severe coughing. No systemic disease
or past ophthalmic history was reported. Her BCVAwas 6/15 in the
right eye and 6/6 in the left eye. No elevation of IOP was noted.vier Taiwan LLC. All rights reserved.
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macular hemorrhage near the inferior arcade encroaching upon the
fovea in the right eye (Figs. 1A and 1B). OCT revealed a dome-
shaped hyporeﬂective area beneath a hyper-reﬂective band at the
fovea (Fig. 1C), compatible with sub-ILM hemorrhage.
The patient received an intravitreal tPA injection followed by a
C3F8 pneumopexy. Multiple follow-up examinations were sched-
uled on the 3rd day, the 10th day, the 24th day, the 6th week, the 8th
week, the 4th month, and the 6th month after the treatment.
Postoperative BCVA of the right eye improved to 6/8.6 on the 3rd
day, 6/7.5 on the 24th day, and was 6/6 consistently after the 8th
week. No elevation of IOP was noted during the visits. Post-
treatment fundus photography revealed signiﬁcant absorption of
the hemorrhage (Figs. 1DeF). Repeated FAs revealed no active
lesion throughout the follow-up period (Figs. 1G and 1H). OCT
demonstrated gradual absorption of the hemorrhage in the sub-
ILM space (Figs. 1IeN).
2.2. Case 2
A 20-year-old woman, treated with chemotherapy for acute
promyelocytic leukemia, with severe anemia and thrombocyto-
penia, was referred to our clinic due to acute vision loss and
bilateral retinal hemorrhages. Her BCVA was 6/8.6 in the right eye
and 3/60 in the left eye. No elevation of IOP was noted. Fundus
photography disclosed several macular hemorrhages in the right
eye and a large area of sub-ILM hemorrhage involving the fovea ofFig. 1. At the initial presentation of the right eye, (A) fundus photograph and (B) ﬂuoresc
encroaching upon the fovea and (C) the vertical scan of optical coherence tomography (OCT)
inferior arcade, suggesting that the hemorrhage corresponded to the sub-internal limiting m
10 days, (E) 8 weeks, and (F) 4 months after injection. Postoperative ﬂuorescein angiograp
complete blood absorption with no neovascularization 6 months after injection. OCT demon
days, (K) 6 weeks, (L) 8 weeks, (M) 4 months, and (N) 6 months after injection.the left eye (Fig. 2A). FA demonstrated ﬂuorescence blockage in the
fovea (Fig. 2B) and OCT conﬁrmed the sub-ILM location (Fig. 2C).
Initially the management for the hemorrhage was suspended
due to leukopenia (White blood cell: 270/mm3). After 1 month,
when the condition became stable, preoperative examinations
were performed and fundus photograph, FA, and OCT showed a
partially organized sub-ILM hemorrhage with residual blood in the
fovea of the left eye (Figs. 2DeF). Her BCVA remained 3/60 in the
left eye. The patient received an intravitreal tPA injection followed
by a C3F8 pneumopexy. Multiple follow-up examinations were
carried out on the 3rd day, the 5th day, the 10th day, the 18th day, the
4th week, the 6th week, and the 2nd month after treatment. Post-
operative BCVA of the left eye improved to 5/60 on the 3rd day, 6/60
on the 5th day, 6/6 on the 10th day, and was 6/6 consistently af-
terward. No elevation of IOP was noted during the visits. Post-
treatment fundus photography showed signiﬁcant absorption of
the hemorrhage (Figs. 2GeI). No recurrent bleeding or neo-
vascularization was noted in the FA on the visit of the 18th day
(Fig. 2J). Gradual blood absorption in the sub-ILM space was
demonstrated in OCT and a translucent prefoveolar cavity with
overriding stretched ILM was disclosed (Figs. 2KeQ).
3. Discussion
Various causes of sub-ILM hemorrhage have been reported.1
Valsalva retinopathy may be associated with a rupture of peri-
foveal retinal capillaries caused by a rapid increase in intraocularein angiography revealed a well-circumscribed hemorrhage near the inferior arcade
demonstrated a dome-shaped, hyporeﬂective area under a hyper-reﬂective band at the
embrane space. Absorption of the hemorrhage was found under fundus photograph (D)
hy showed blockage of the residual hemorrhage (G) 8 weeks after injection and (H)
strated gradual blood absorption with no postoperative complications (I) 10 days, (J) 24
Fig. 2. At the initial presentation of the left eye, (A) fundus photograph and (B) ﬂuorescein angiography revealed a large area of sub-internal limiting membrane (ILM) hemorrhage
involving the fovea and (C) the vertical scan of optical coherence tomography (OCT) demonstrated a dome-shaped blood clot under a hyper-reﬂective band, conﬁrming the sub-ILM
hemorrhage. Preoperative (D) fundus photograph, (E) ﬂuorescein angiography, and (F) OCT showed the remaining hemorrhage and the partially organized blood clot in the fovea.
Postoperative fundus photograph revealed blood absorption (G) 10 days, (H) 4 weeks, and (I) 2 months after injection. (J) Postoperative ﬂuorescein angiography disclosed the blood
absorption with no recurrent bleeding or neovascularization 18 days after injection. Postoperative OCT demonstrated the gradual absorption of the hemorrhage with the formation
of the sub-ILM cavity with overriding stretched ILM (K) 3 days, (L) 5 days, (M) 10 days, (N) 18 days, (O) 4 weeks, (P) 6 weeks, and (Q) 2 months after injection.
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pressure, such as coughing, sneezing, or strenuous physical activ-
ity.5 In most cases, the extravasated blood is sedimented under the
ILM.6 Blood dyscrasia, such as anemia and thrombocytopenia, may
be an important risk factor for developing retinopathy.7 It is
believed that the reduction of coagulability and endothelial cell
integrity of the retinal vasculature allows the blood cells to leak
through the endothelial barrier of the retinal capillaries.1
Although the spontaneous absorption of hemorrhage less than
one disk in diameter tends to resolve in a short period of time, a
larger area of blood clot may take months to clear.2 Due to the
rareness of the disease, reported complications of long-term un-
treated sub-ILM hemorrhage are not found. However, it is well
understood that prolonged retinal contact with hemoglobin and
iron may cause toxic retinal damage and lead to irreversible visual
impairment.8,9 Different managements for sub-ILM hemorrhage
have been reported.1,2 Nd:YAG laser is effective in clearing the
hemorrhage from Valsalva retinopathy by puncturing the ILM.3
However, Garcia Fernandez et al2 suggested that Nd:YAG laser
should be used to treat premacular hemorrhage instead of sub-ILM
hemorrhage due to complications such as retinal hole formation or
retinal detachment. Pars plana vitrectomy has been used for im-
mediate removal of the hemorrhage and for the conﬁrmation of the
bleeding location.1 Complications may occur including bleeding,
cataract, increased IOP, and retinal detachment.1 Vitrectomy is
suggested for dense hemorrhage or insufﬁcient spontaneous ab-
sorption in Valsalva retinopathy.2
Intravitreal injection of tPA followed by pneumopexy has been
reported effective in treating subretinal and subhyaloidhemorrhage.4,10 As an enzyme, tPA catalyzes the conversion of
plasminogen to plasmin, which is responsible for ﬁbrinolysis and
blood clot breakdown. In Patient 2, we found intravitreal injection
of tPA effective in dissolving the partially organized blood clot even
when the treatment was delayed for 1 month. In this study, we
injected 50 mg of tPA intravitreally to treat the sub-ILM hemorrhage.
This dosage is considered safe to avoid retinal toxicity and sufﬁcient
for blood clot lysis in subretinal hemorrhages.4 We found that
successful blood clot lysis was achieved without tPA-related retinal
toxicity in our patients. In the treatment of subretinal hemorrhage,
it is believed that tPA may diffuse into the subretinal space through
the microlesions in the retina caused by stretching from the hem-
orrhage.11 We believe that this hypothesis explains the passage of
tPA into the sub-ILM space in our cases.
In submacular hemorrhage, intravitreal gas injection followed
by prone positioning is effective in displacing the thick hemorrhage
from the fovea.12 We believe that an intravitreal gas injection after
tPA hemolysis could be used as pneumopexy for ILM detachment
caused by the hemorrhage. In the treatment of subretinal hemor-
rhage using a tPA injection with a pneumatic injection, a delay of
3e6 hours before the gas injection is sufﬁcient to allow tPA to
migrate across the retina.13 Because of the proximity of the blood to
the retinal surface in sub-ILM hemorrhages, a delay of 4 hours in
our cases led to a successful outcome of tPA hemolysis and blood
absorption.
A translucent cavity under a hyper-reﬂective membrane, pre-
sumably the ILM, was disclosed in the second case after treatment.
It is believed that the growth factors contained in the blood may
stimulate the cells along the outer ILM and retinal surface and cause
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was resolved.14 This occurs mainly in cases of sub-ILM hemorrhage
and may not be resolved with observation alone.14
Unlike the natural course of recovery, the hemorrhage was
effectively absorbed with faster visual recovery in both cases. We
observed neither complications nor progression despite the lack of
immediate hemorrhage removal by vitrectomy or laser puncturing.
This result suggested that tPA hemolysis with intravitreous injec-
tion and pneumopexy was a safe and effective method to treat sub-
ILM hemorrhage. Further large-scale and long-term studies may be
suggested for further evaluation of the beneﬁts and disadvantages
of this therapy.References
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